➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 211589

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 211589 describes SUCCINYLCHOLINE CHLORIDE, which is a drug marketed by Accord Hlthcare, Amneal, Amphastar Pharms Inc, Amring Pharms, Aspiro, Breckenridge, Deva Holding As, Dr Reddys, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Indoco, Intl Medication, Micro Labs, Nexus Pharms, Nivagen Pharms Inc, Organon Usa Inc, Sagent Pharms Inc, Somerset Theraps Llc, and Zydus Pharms, and is included in twenty NDAs. It is available from twenty-three suppliers. Additional details are available on the SUCCINYLCHOLINE CHLORIDE profile page.

The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There are six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Summary for 211589
Applicant:Somerset Theraps Llc
Ingredient:succinylcholine chloride
Formulation / Manufacturing:see details
Pharmacology for NDA: 211589
Medical Subject Heading (MeSH) Categories for 211589
Suppliers and Packaging for NDA: 211589
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SUCCINYLCHOLINE CHLORIDE succinylcholine chloride INJECTABLE;INJECTION 211589 ANDA Somerset Therapeutics, LLC 70069-301 70069-301-25 25 VIAL in 1 CARTON (70069-301-25) > 10 mL in 1 VIAL (70069-301-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/ML
Approval Date:Jan 15, 2020TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.